DLA Piper has advised Ping An Healthcare and Technology Company Limited (Ping An Good Doctor), a subsidiary of Ping An Insurance Group, on its pre-IPO restructuring which enabled the city's biggest IPO to-date, with a valuation of approximately US$7.5 billion.

Ping An Good Doctor is the world's leading healthcare portal in terms of traffic, with over 190 million registered users and more than 30 million monthly active users.

Corporate partner James Chang, who led the team advising on this transaction, said: "I am delighted to have advised our longstanding client Ping An Group on this landmark deal, which is set to be one of the most high-profile IPOs in Hong Kong this year. This project demonstrates great team work with teams in Beijing, Shanghai and Hong Kong working closely together on the negotiations with multiple parties and the preparation of the transaction documents."

The team also included Asia Senior Partner, Roy Chan, assisted by associate Lily Li, and legal assistants Qin Gu and David Zhang. Asia Head of Corporate and Head of Funds and Investment Management Luke Gannon, together with associate Karen Cheng also advised on the transaction. Asia Head of Finance, Projects and Restructuring, Matthias Schemuth, advised on finance aspects while Corporate partner Christina Loh advised on Hong Kong securities law aspects of the transaction.

DLA Piper also advised Ping An Good Doctor on its Series A financing back in April 2016.